Antibiotic Treatment of Mycobacterium abscessus Lung Disease
- 1 November 2009
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 180 (9), 896-902
- https://doi.org/10.1164/rccm.200905-0704oc
Abstract
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess the efficacy of a standardized combination antibiotic therapy for the treatment of M. abscessus lung disease. Methods: Sixty-five patients (11 males, 55 females, median age 55 yr) with M. abscessus lung disease were treated with clarithromycin, ciprofloxacin, and doxycycline, together with an initial regimen of amikacin and cefoxitin for the first 4 weeks of hospitalization. Measurements and Main Results: Treatment response rates were 83% for symptoms and 74% for high-resolution computed tomography. Sputum conversion and maintenance of negative sputum cultures for more than 12 months was achieved in 38 (58%) patients. These rates were significantly lower in patients whose isolates were resistant to clarithromycin (17%, 2/12) compared with those whose isolates were susceptible or intermediate to clarithromycin (64%, 21/33; P = 0.007). Neutropenia and thrombocytopenia associated with cefoxitin developed in 33 (51%) and 4 (6%) patients, respectively. Drug-induced hepatotoxicity occurred in 10 (15%) patients. Because of these adverse reactions, cefoxitin was discontinued in 39 (60%) patients after treatment for a median of 22 days. Conclusions: Standardized combination antibiotic therapy was moderately effective in treating M. abscessus lung disease. However, frequent adverse reactions and the potential for long-duration hospitalization are important problems that remain to be solved.This publication has 39 references indexed in Scilit:
- Diagnosis and Treatment of Infections Caused by Rapidly Growing MycobacteriaSeminars in Respiratory and Critical Care Medicine, 2008
- Spread of nontuberculous mycobacteria from 1993 to 2006 in KoreansJournal of Clinical Laboratory Analysis, 2008
- Rapidly Growing MycobacteriaAmerican Journal of Clinical Pathology, 2007
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophagesScandinavian Journal of Infectious Diseases, 2007
- Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in KoreaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Pulmonary disease caused by rapidly growing mycobacteriaClinics in Chest Medicine, 2002
- Cytomegalovirus: The Monster in the Closet?American Journal of Respiratory and Critical Care Medicine, 1997
- Clinical Features of Pulmonary Disease Caused by Rapidly Growing Mycobacteria: An Analysis of 154 PatientsAmerican Review of Respiratory Disease, 1993
- Spectrum of Disease Due to Rapidly Growing MycobacteriaClinical Infectious Diseases, 1983